Partnering Solutions
-
Getting Biotechs GlobalReady
8/8/2024
Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.
-
Immune Challenge Models For Early Drug Development
10/9/2025
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
-
Safe-To-Site Initiative
12/8/2025
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
-
Avance Clinical's Specialist Areas Of Focus
8/8/2024
Avance Clinical offers deep scientific expertise and extensive knowledge across a range of specialized therapeutic indications, consistently achieving global regulatory approvals.
-
Clinical Pharmacology Services
3/14/2025
With over 30 years of proven experience, we provide comprehensive clinical pharmacology services, from data management and analysis to the generation of clinical study reports.
-
Accelerate Drug Development With Innovative 360˚ CDMO And CRO Solutions
6/9/2026
Accelerator™ Drug Development provides a strategic, end-to-end partnership model that helps sponsors optimize resources, overcome development challenges, and advance promising therapies.
-
Supporting Sites And Patients With People-First Solutions
12/6/2024
Discover how Scout supports patient retention with people-first solutions for reimbursement and travel at no cost to sites.
-
The Fastest-Growing Trial Operations Platform
6/15/2026
A unified platform connects teams, digitizes workflows, and delivers real-time insights to speed study startup, strengthen oversight, and keep trials inspection-ready end to end.
-
Introducing One Home for Sites™
2/8/2024
One Home for Sites is a vendor-agnostic, sponsor-agnostic, aggregation platform that provides single sign-on and more. Become part of the only industry-wide solution to site tech overload.
-
Early-Phase Oncology Research Expertise
11/17/2025
Our priority is guiding promising therapies to proof-of-concept with precision and urgency, because every day saved in development matters profoundly to patients living with cancer.